FDA fi­nal­ly ap­proves Reata's rare ge­net­ic dis­ease drug

Af­ter rais­ing se­ri­ous ef­fi­ca­cy ques­tions, the FDA this evening ap­proved Rea­ta Phar­ma­ceu­ti­cals’ drug for a rare ge­net­ic dis­ease known as Friedre­ich’s atax­ia, which af­fects the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER